AFAS
TARO

Acorn Financial Advisory Services’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Acorn Financial Advisory Services’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,377
Closed -$305K – 247
2021
Q2 		$305K Buy
+1,377
New +$101K 0.09% 195

Other funds holding TARO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acorn Financial Advisory Services's TARO Position: Q3 2021 in Review

Acorn Financial Advisory Services sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q3 2021, closing a stake of 1,377 shares — an estimated $305K sold.

Acorn Financial Advisory Services first reported a position in TARO in Q2 2021 and held it in 1 quarter. The position peaked at $305K in Q2 2021. 71 funds tracked by Wall St. Rank hold TARO as of Q3 2021.

  • Acorn Financial Advisory Services reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q3 2021 after selling out during the quarter.
  • Acorn Financial Advisory Services sold 1,377 Taro Pharmaceutical Industries Ltd. shares in Q3 2021, an estimated $305K.
  • Acorn Financial Advisory Services first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2021 and held it in 1 quarter.
  • Acorn Financial Advisory Services's Taro Pharmaceutical Industries Ltd. position peaked at $305K in Q2 2021.
  • 71 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2021.

Based on Acorn Financial Advisory Services's 13F filing for Q3 2021, filed 15 Nov 2021.